Literature DB >> 22824161

Cardiac performance and quality of life in patients who have undergone the Fontan procedure with and without prior superior cavopulmonary connection.

Andrew M Atz1, Thomas G Travison, Brian W McCrindle, Lynn Mahony, Andrew C Glatz, Aditya K Kaza, Roger E Breitbart, Steven D Colan, Jonathan R Kaltman, Renee Margossian, Sara K Pasquali, Yanli Wang, Welton M Gersony.   

Abstract

BACKGROUND: A superior cavopulmonary connection is commonly performed before the Fontan procedure in patients with a functionally univentricular heart. Data are limited regarding associations between a prior superior cavopulmonary connection and functional and ventricular performance late after the Fontan procedure.
METHODS: We compared characteristics of those with and without prior superior cavopulmonary connection among 546 subjects enrolled in the Pediatric Heart Network Fontan Cross-Sectional Study. We further compared different superior cavopulmonary connection techniques: bidirectional cavopulmonary anastomosis (n equals 229), bilateral bidirectional cavopulmonary anastomosis (n equals 39), and hemi-Fontan (n equals 114).
RESULTS: A prior superior cavopulmonary connection was performed in 408 subjects (75%); the proportion differed by year of Fontan surgery and centre (p-value less than 0.0001 for each). The average age at Fontan was similar, 3.5 years in those with superior cavopulmonary connection versus 3.2 years in those without (p-value equals 0.4). The type of superior cavopulmonary connection varied by site (p-value less than 0.001) and was related to the type of Fontan procedure. Exercise performance, echocardiographic variables, and predominant rhythm did not differ by superior cavopulmonary connection status or among superior cavopulmonary connection types. Using a test of interaction, findings did not vary according to an underlying diagnosis of hypoplastic left heart syndrome.
CONCLUSIONS: After controlling for subject and era factors, most long-term outcomes in subjects with a prior superior cavopulmonary connection did not differ substantially from those without this procedure. The type of superior cavopulmonary connection varied significantly by centre, but late outcomes were similar.

Entities:  

Mesh:

Year:  2012        PMID: 22824161      PMCID: PMC3578173          DOI: 10.1017/S1047951112001175

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  19 in total

1.  Natural history and patterns of recovery of contractile function in single left ventricle after Fontan operation.

Authors:  T Sluysmans; S P Sanders; M van der Velde; A Matitiau; I A Parness; P J Spevak; J E Mayer; S D Colan
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

2.  Impact of early ventricular unloading on exercise performance in preadolescents with single ventricle Fontan physiology.

Authors:  W T Mahle; G Wernovsky; N D Bridges; A B Linton; S M Paridon
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

3.  Theoretical and empirical derivation of cardiovascular allometric relationships in children.

Authors:  Thierry Sluysmans; Steven D Colan
Journal:  J Appl Physiol (1985)       Date:  2004-11-19

4.  What factors affect ventricular performance after a Fontan-type operation?

Authors:  H Uemura; T Yagihara; Y Kawashima; F Yamamoto; K Nishigaki; O Matsuki; K Okada; T Kamiya; R H Anderson
Journal:  J Thorac Cardiovasc Surg       Date:  1995-08       Impact factor: 5.209

5.  Fontan's procedure in two stages.

Authors:  W I Norwood; M L Jacobs
Journal:  Am J Surg       Date:  1993-11       Impact factor: 2.565

6.  Bidirectional cavopulmonary anastomosis as interim palliation for high-risk Fontan candidates. Early results.

Authors:  N D Bridges; R A Jonas; J E Mayer; M F Flanagan; J F Keane; A R Castaneda
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

7.  The bidirectional cavopulmonary shunt.

Authors:  J J Lamberti; R L Spicer; J D Waldman; T M Grehl; D Thomson; L George; S E Kirkpatrick; J W Mathewson
Journal:  J Thorac Cardiovasc Surg       Date:  1990-07       Impact factor: 5.209

8.  Modifications to the cavopulmonary anastomosis do not eliminate early sinus node dysfunction.

Authors:  M I Cohen; N D Bridges; J W Gaynor; T M Hoffman; G Wernovsky; V L Vetter; T L Spray; L A Rhodes
Journal:  J Thorac Cardiovasc Surg       Date:  2000-11       Impact factor: 5.209

9.  Factors associated with serum brain natriuretic peptide levels after the Fontan procedure.

Authors:  Andrew M Atz; Victor Zak; Roger E Breitbart; Steven D Colan; Sara K Pasquali; Daphne T Hsu; Minmin Lu; Lynn Mahony; Stephen M Paridon; Michael D Puchalski; Tal Geva; Brian W McCrindle
Journal:  Congenit Heart Dis       Date:  2011-03-25       Impact factor: 2.007

10.  Sinus node function after a systematically staged Fontan procedure.

Authors:  M I Cohen; G Wernovsky; V L Vetter; T S Wieand; J W Gaynor; M L Jacobs; T L Spray; L A Rhodes
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

View more
  4 in total

1.  Introduction to the series: challenges and opportunities in pediatric heart failure and transplantation.

Authors:  Daniel Bernstein
Journal:  Circulation       Date:  2014-01-07       Impact factor: 29.690

Review 2.  "Functionally" univentricular hearts: impact of pre-natal diagnosis.

Authors:  Antonio Francesco Corno
Journal:  Front Pediatr       Date:  2015-02-27       Impact factor: 3.418

3.  Exercise performance after univentricular palliation.

Authors:  Sachin Talwar; Manikala Vinod Kumar; Vishnubhatla Sreenivas; Vishwa Prakash Gupta; Shiv Kumary Choudhary; Balram Airan
Journal:  Ann Pediatr Cardiol       Date:  2018 Jan-Apr

4.  Health-Related Quality of Life in Children, Adolescents, and Adults With a Fontan Circulation: A Meta-Analysis.

Authors:  Kate H Marshall; Yves D'Udekem; Gary F Sholler; Alexander R Opotowsky; Daniel S J Costa; Louise Sharpe; David S Celermajer; David S Winlaw; Jane W Newburger; Nadine A Kasparian
Journal:  J Am Heart Assoc       Date:  2020-03-16       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.